Related Experiment Videos
Imipenem-cilastatin: the promise of single-agent antimicrobial therapy fulfilled?
Clinical Pharmacy
|September 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses as Support for Meropenem-Vaborbactam Dosing Regimens and Susceptibility Breakpoints.
Antimicrobial agents and chemotherapy·2022
Population Pharmacokinetics of Meropenem and Vaborbactam Based on Data from Noninfected Subjects and Infected Patients.
Antimicrobial agents and chemotherapy·2021
In vitro activities of RWJ-54428 (MC-02,479) against multiresistant gram-positive bacteria.
Antimicrobial agents and chemotherapy·2001
SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems.
The Journal of antibiotics·2001
Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.
Current opinion in microbiology·2000
A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.
Antimicrobial agents and chemotherapy·2000
Efficacy of nutritional supplements used by athletes.
Clinical pharmacy·1993
Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
Clinical pharmacy·1993
Sotalol: a new class III antiarrhythmic agent.
Clinical pharmacy·1993
Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
Clinical pharmacy·1993
Pathophysiology of septic shock and implications for therapy.
Clinical pharmacy·1993
Cladribine for the treatment of hematologic malignancies.
Clinical pharmacy·1993
APOBEC3 Knockout in Lentiviral Packaging Cells Improves Therapeutic Transgene Sequence Fidelity.
Molecular therapy : the journal of the American Society of Gene Therapy·2026
PRDM16 as a Multifaceted Pharmacological Target in Kidney Diseases: From Epigenetic Mechanisms to Therapeutic Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Olmesartan-Loaded PLGA Nanoparticles Attenuate Methotrexate-Induced Kidney Injury: Association with the AT1R/ERK1/2 Signaling Axis.
Pharmaceuticals (Basel, Switzerland)·2026